356 related articles for article (PubMed ID: 8895181)
1. Epidemiologic studies of the association of L-tryptophan with the eosinophilia-myalgia syndrome: a critique.
Shapiro S
J Rheumatol Suppl; 1996 Oct; 46():44-58; discussion 58-9. PubMed ID: 8895181
[TBL] [Abstract][Full Text] [Related]
2. Bias or biology: evaluating the epidemiologic studies of L-tryptophan and the eosinophilia-myalgia syndrome.
Horwitz RI; Daniels SR
J Rheumatol Suppl; 1996 Oct; 46():60-72. PubMed ID: 8895182
[TBL] [Abstract][Full Text] [Related]
3. Tryptophan produced by Showa Denko and epidemic eosinophilia-myalgia syndrome.
Kilbourne EM; Philen RM; Kamb ML; Falk H
J Rheumatol Suppl; 1996 Oct; 46():81-8; discussion 89-91. PubMed ID: 8895184
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for developing eosinophilia myalgia syndrome among L-tryptophan users in New York.
Back EE; Henning KJ; Kallenbach LR; Brix KA; Gunn RA; Melius JM
J Rheumatol; 1993 Apr; 20(4):666-72. PubMed ID: 8496862
[TBL] [Abstract][Full Text] [Related]
5. Review of L-tryptophan and eosinophilia-myalgia syndrome.
Roufs JB
J Am Diet Assoc; 1992 Jul; 92(7):844-50. PubMed ID: 1624654
[TBL] [Abstract][Full Text] [Related]
6. Eosinophilia-myalgia syndrome among the non-L-tryptophan users and pre-epidemic cases.
Sullivan EA; Staehling N; Philen RM
J Rheumatol; 1996 Oct; 23(10):1784-7. PubMed ID: 8895159
[TBL] [Abstract][Full Text] [Related]
7. Animal models of the eosinophilia-myalgia syndrome.
Clauw DJ
J Rheumatol Suppl; 1996 Oct; 46():93-7; discussion 92, 97-8. PubMed ID: 8895185
[TBL] [Abstract][Full Text] [Related]
8. [A case of the eosinophilia-myalgia syndrome].
Ishikawa A; Akahosi T; Okada J; Kondo H; Kasiwazaki S
Ryumachi; 1992 Aug; 32(4):327-30; discussion 330-2. PubMed ID: 1411794
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of patients with diffuse fasciitis and eosinophilia associated with L-tryptophan ingestion.
Beko E; Pervaiz S; Nanda V; Dhawan S
Cutis; 1993 Apr; 51(4):266-70. PubMed ID: 8477608
[TBL] [Abstract][Full Text] [Related]
10. ["Eosinophilia-myalgia" syndrome due to L-tryptophan containing products. Cooperative evaluation of French Regional Centers of Pharmacovigilance. Analysis of 24 cases].
Castot A; Bidault I; Bournerias I; Carlier P; Efthymiou ML
Therapie; 1991; 46(5):355-65. PubMed ID: 1754978
[TBL] [Abstract][Full Text] [Related]
11. Idiopathic and L-tryptophan-associated eosinophilic fasciitis before and after L-tryptophan contamination.
Blauvelt A; Falanga V
Arch Dermatol; 1991 Aug; 127(8):1159-66. PubMed ID: 1863073
[TBL] [Abstract][Full Text] [Related]
12. [Eosinophilia-myalgia syndrome after L-tryptophan intake].
Zillikens D; Bammel A; Lurz C; Elsner P; Burg G
Hautarzt; 1991 Mar; 42(3):154-7. PubMed ID: 2055764
[TBL] [Abstract][Full Text] [Related]
13. [Eosinophilia-myalgia syndrome].
Kotake S; Kashiwazaki S
Nihon Rinsho; 1992 Jul; 50(7):1650-5. PubMed ID: 1404896
[TBL] [Abstract][Full Text] [Related]
14. The natural history of eosinophilia-myalgia syndrome in a tryptophan-exposed cohort in South Carolina.
Sullivan EA; Kamb ML; Jones JL; Meyer P; Philen RM; Falk H; Sinks T
Arch Intern Med; 1996 May; 156(9):973-9. PubMed ID: 8624177
[TBL] [Abstract][Full Text] [Related]
15. L-tryptophan implicated in human eosinophilia-myalgia syndrome causes fasciitis and perimyositis in the Lewis rat.
Crofford LJ; Rader JI; Dalakas MC; Hill RH; Page SW; Needham LL; Brady LS; Heyes MP; Wilder RL; Gold PW
J Clin Invest; 1990 Nov; 86(5):1757-63. PubMed ID: 2243145
[TBL] [Abstract][Full Text] [Related]
16. Eosinophilia-myalgia syndrome in patients ingesting a single source of L-tryptophan.
Henning KJ; Jean-Baptiste E; Singh T; Hill RH; Friedman SM
J Rheumatol; 1993 Feb; 20(2):273-8. PubMed ID: 8474064
[TBL] [Abstract][Full Text] [Related]
17. L-tryptophan-associated eosinophilic fasciitis prior to the 1989 eosinophilia-myalgia syndrome outbreak.
Hibbs JR; Mittleman B; Hill P; Medsger TA
Arthritis Rheum; 1992 Mar; 35(3):299-303. PubMed ID: 1536667
[TBL] [Abstract][Full Text] [Related]
18. Eosinophilic fasciitis associated with tryptophan ingestion. A manifestation of eosinophilia-myalgia syndrome.
Gordon ML; Lebwohl MG; Phelps RG; Cohen SR; Fleischmajer R
Arch Dermatol; 1991 Feb; 127(2):217-20. PubMed ID: 1990986
[TBL] [Abstract][Full Text] [Related]
19. Eosinophilic fasciitis is clinically distinguishable from the eosinophilia-myalgia syndrome and is not associated with L-tryptophan use.
Varga J; Griffin R; Newman JH; Jimenez SA
J Rheumatol; 1991 Feb; 18(2):259-63. PubMed ID: 2023221
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic bias in clinical decision making: an example of L-tryptophan and the diagnosis of eosinophilia-myalgia syndrome.
Wagner KR; Elmore JG; Horwitz RI
J Rheumatol; 1996 Dec; 23(12):2079-85. PubMed ID: 8970044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
